Astellas Venture Management
Profile and portfolio
Astellas Venture Management is the corporate venture arm of Astellas Pharma, a pharmaceutical and biotech company. It was founded in 2006 and is based in South San Francisco, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Active | 21 | 58.3% |
| Exited | 15 | 41.7% |
Status as the firm tags it
Sources: S3 Astellas Venture Management: portfolio.
Where it invests and who leads it
Geography
- Headquarters
- South San Francisco, United States
- Offices
- South San Francisco, United States
Investment regionsS1S3
LeadersS2
- Satoshi KonagaiInvestment LeadFind on LinkedInFirm page
- Tadayoshi HirataInvestment LeadFind on LinkedInFirm page
- Shinichi MiyakeInvestment LeadFind on LinkedInFirm page
- Hiroyuki UsudaInvestment LeadFind on LinkedInFirm page
- Amy SkarrPresident (Board of Managers listing)Find on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Astellas Pharma | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2006 | Single source | S7 |
| Headquarters | South San Francisco, United States | Single source | S6 |
| Status | Active | Single source | S4 |
| Capital source | Parent company only | Single source | S1 |
| Companies backed | 21 | Single source | S3 |
| Exits | 5 total | Single source | S3 |
| Stages | Seed, Series A | Single source | S1 |
For founders
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
Recent rounds
Portfolio
The firm's portfolio page lists 36 companies: 21 active, 15 exited.S3
The firm also states 21 companies backed. The page list and the stated total measure different things.S3
| Tag | Companies | Share |
|---|---|---|
| Active | 21 | 58.3% |
| Exited | 15 | 41.7% |
Every company on the Astellas Venture Management list
36 companies, as listed on the firm's own website: 21 active, 15 exited.S3 Read the firm's list.
Active 21
- Avilar Therapeutics
- Carbon Biosciences
- Casma Therapeutics
- Catamaran Bio
- Cellular Intelligence
- DEM BioPharma
- Mogrify
- NeoPhore
- Orna Therapeutics Holdings
- Pallando Therapeutics
- PhoreMost
- ResNovas Therapeutics
- Restore Vision
- Shinobi Therapeutics
- Sidewinder Therapeutics
- Solu Therapeutics
- Stealth mode Company (Invested in 2022 Feb)
- Syntax Bio
- Toregem BioPharma
- Turn Biotechnologies
- Weaver Biosciences
Exited 15
- Bicycle Therapeutics
- Cleave Biosciences
- CODA Biotherapeutics
- Crescendo Biologics
- eFFECTOR Therapeutics
- F2G
- Heartseed
- Oncorus
- PanOptica
- Redona Therapeutics
- Tizona Therapeutics
- Trieza Therapeutics
- Trishula Terapeutics
- TScan Therapeutics
- Viamet Pharmaceuticals
History
- Astellas Pharma establishes Astellas Venture Management LLC (then headquartered in Los Altos, CA) to manage the former Yamanouchi and Fujisawa venture business plus a new Astellas Venture Fund.S7
- William Watt joins AVM as President on 1 June (older staging team page).S5
- Hiroyuki Usuda joins AVM as Investment Lead.S2
Official pages
Read the firm's own pages for current information.
Sources
- S1Astellas Venture Management: homeFirm
- S2Astellas Venture Management: teamFirm
- S3Astellas Venture Management: portfolioFirm
- S4Astellas Venture Management: newsFirm
- S5Astellas Venture Management: team (older staging copy)Firm
- S6Astellas Venture Management: contactFirm
- S7Astellas newsroom: Astellas Has Established Astellas Venture Management in the USParent company
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Astellas Venture Management or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.